We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+16.46%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$484M
AUM Growth
+$15.4M
Cap. Flow
-$55.9M
Cap. Flow %
-11.54%
Top 10 Hldgs %
55.19%
Holding
34
New
3
Increased
8
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$25.6M
2
GILD icon
Gilead Sciences
GILD
+$18M
3
CERN
Cerner Corp
CERN
+$5.86M
4
HCA icon
HCA Healthcare
HCA
+$3.67M
5
MRK icon
Merck
MRK
+$2.28M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$17M
2
UTHR icon
United Therapeutics
UTHR
+$15.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$12.7M
4
ABT icon
Abbott
ABT
+$9.8M
5
BSX icon
Boston Scientific
BSX
+$9.35M

Sector Composition

Rank Sector Weight
1 Healthcare 98.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERN
26
DELISTED
Cerner Corp
CERN
$5.85M 1.21%
+85,300
New +$5.86M
ELAN icon
27
Elanco Animal Health
ELAN
$12.6B
$5.53M 1.14%
257,891
-243,871
-49% -$5.39M
LIVN icon
28
LivaNova
LIVN
$4.35B
$5.25M 1.08%
109,110
+37,710
+53% +$1.89M
PTCT icon
29
PTC Therapeutics
PTCT
$6.47B
$4.59M 0.95%
90,396
+14,400
+19% +$708K
JNJ icon
30
Johnson & Johnson
JNJ
$599B
$4.26M 0.88%
30,279
-87,253
-74% -$12.7M
HCA icon
31
HCA Healthcare
HCA
$82.2B
$3.42M 0.71%
+35,276
New +$3.67M
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
$2.38M 0.49%
353,085
-23,000
-6% -$174K
BLUE
33
DELISTED
bluebird bio
BLUE
– –
-3,743
Closed -$2.23M
UTHR icon
34
United Therapeutics
UTHR
$22.5B
– –
-162,554
Closed -$15.4M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2020 Portfolio in Review

As of Q2 2020, Sector Gamma AS held 34 positions worth $484M, up 3.3% from $469M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sector Gamma AS withdrew a net $55.9M in Q2 2020, closing 2 positions and reducing 21 holdings. Its most notable exit was United Therapeutics, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Medtronic worth $24.5M.

  • Sector Gamma AS's largest Q2 2020 buy was Medtronic: 266,800 shares worth $24.5M.
  • Sector Gamma AS added most to Gilead Sciences in Q2 2020, an estimated $18M increase.
  • Sector Gamma AS's biggest Q2 2020 reduction was Incyte, cutting an estimated $17M.
  • Sector Gamma AS fully exited United Therapeutics in Q2 2020, selling an estimated $15.4M.
  • Sector Gamma AS's ten largest holdings make up 55% of its $484M portfolio in Q2 2020.
  • Sector Gamma AS opened 3 new positions and closed 2 in Q2 2020.
  • Sector Gamma AS's portfolio value rose 3.3% quarter-over-quarter to $484M.

Based on Sector Gamma AS's 13F filing for Q2 2020, filed 7 Aug 2020.